UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence

International journal of hematology, 2022-03, Vol.115 (3), p.336-349

2022

Volltextzugriff (PDF)

Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial

International journal of hematology, 2021-08, Vol.114 (2), p.205-216

2021

Volltextzugriff (PDF)

Prognostic Significance of Asymptomatic Cerebral Infarction in Patients After Cardiac Catheterization

International Heart Journal, 2024/01/31, Vol.65(1), pp.13-20

2024

Volltextzugriff (PDF)

Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma

Cancer science, 2022-02, Vol.113 (2), p.660-673

2022

Volltextzugriff (PDF)

The Impact of Hemodialysis and Liver Cirrhosis on the Plasma Concentrations of Tyrosine Kinase Inhibitors in a Patient with Chronic Myeloid Leukemia

Internal Medicine, 2020/11/01, Vol.59(21), pp.2745-2749

2020

Volltextzugriff (PDF)

Comparative Analysis of the Hemodynamic Effects of Remimazolam and Propofol During General Anesthesia: A Retrospective Study

Curēus (Palo Alto, CA), 2024-04

2024

Volltextzugriff (PDF)

Plaque characteristics and prognosis in patients with peripheral arterial disease by angioscopic analysis

Journal of cardiology, 2022-07, Vol.80 (1), p.94-100

2022

Volltextzugriff (PDF)

Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma

Journal of Clinical and Experimental Hematopathology, 2023, Vol.63(2), pp.99-107

2023

Volltextzugriff (PDF)

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial)

International journal of hematology, 2018-05, Vol.107 (5), p.535-540

2018

Volltextzugriff (PDF)

HIV-negative Primary Bone Marrow Hodgkin Lymphoma Manifesting with a High Fever Associated with Hemophagocytosis as the Initial Symptom: A Case Report and Review of the Previous Literature

Internal Medicine, 2015, Vol.54(11), pp.1393-1396

2015

Volltextzugriff (PDF)

The principles and practice of research ethics

Rinshō ketsueki, 2018, Vol.59 (10), p.2380

Hirase, Chikara

2018

Volltextzugriff (PDF)

Cancer types applicable to efficacy assessment using real-world data analyzed from PMDA-approved data

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19272-e19272

2020

Volltextzugriff (PDF)

Efficacy evaluation of anticancer agents in single-arm clinical trials: analysis of review reports from Pharmaceuticals and Medical Devices Agency

Acta oncologica, 2021-02, Vol.60 (2), p.143-148

2021

Volltextzugriff (PDF)

Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide

International journal of hematology, 2011-12, Vol.94 (6), p.583-584

2011

Volltextzugriff (PDF)

Cellular senescence induction by retinoid on adult T-cell leukemia cells

Retrovirology, 2011-06, Vol.8 (S1), p.A31-A31, Article A31

2011

Volltextzugriff (PDF)

Trib1 and Trib2 inhibit granulocytic differentiation by suppressing Akt pathway

Acta Medica Kinki University, 2014-06, Vol.39 (1), p.29-37

2014

Volltextzugriff (PDF)

Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate

International journal of hematology, 2005-05, Vol.81 (4), p.307-309

2005

Volltextzugriff (PDF)

Thromboembolism in TKI therapy

Nihon Kessen Shiketsu Gakkai shi, 2018, Vol.29 (5), p.473-486

2018

Volltextzugriff (PDF)

Efficacy of Rituximab Monotherapy for an Elderly Hemodialysis Patient with Primary Cardiac Lymphoma

Internal Medicine, 2010, Vol.49(19), pp.2163-2166

2010

Volltextzugriff (PDF)

Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL‐6 production in lymphoma cells

British journal of haematology, 2022-07, Vol.198 (2), p.360-372

2022

Volltextzugriff (PDF)

Long-Term Clinical Outcomes of the Patients with Chronic Myeloid Leukemia Treated with Nilotinib as the 1St-Line Tyrosine Kinases Inhibitor at the Kindai university hospital

Acta Medica Kindai University, 2024-06, Vol.49 (1), p.15-25

2024

Volltextzugriff (PDF)

Hypersensitivity of Ph-positive lymphoid cell lines to rapamycin: Possible clinical application of mTOR inhibitor

Leukemia research, 2009-03, Vol.33 (3), p.450-459

2009

Volltextzugriff (PDF)

Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma

Journal of Clinical and Experimental Hematopathology, 2023, Vol.63 (2), p.99-107

2023

Volltextzugriff (PDF)

Analysis of gemcitabine therapy for relapsed or refractory malignant lymphoma in one institute

Annals of oncology, 2015-11, Vol.26, p.vii108

2015

Volltextzugriff (PDF)

Treatment for de novo chronic myeloid leukemia in chronic phase

Nihon rinshō, 2012-04, Vol.70 Suppl 2, p.298

2012

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(50)

Sprache

Englisch
(44)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(26)
Hematology
(17)
Oncology
(12)
Male
(11)
Adult
(10)
Aged
(9)
Female
(9)
Antineoplastic Agents - Therapeutic Use
(7)
Middle Aged
(7)
Medicine
(6)
Medicine & Public Health
(6)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(5)
Patients
(5)
Animals
(4)
Cell Line, Tumor
(4)
Clinical Outcomes
(4)
General & Internal Medicine
(4)
Leukemia
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence

Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial

Prognostic Significance of Asymptomatic Cerebral Infarction in Patients After Cardiac Catheterization

Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma

The Impact of Hemodialysis and Liver Cirrhosis on the Plasma Concentrations of Tyrosine Kinase Inhibitors in a Patient with Chronic Myeloid Leukemia

Comparative Analysis of the Hemodynamic Effects of Remimazolam and Propofol During General Anesthesia: A Retrospective Study

Plaque characteristics and prognosis in patients with peripheral arterial disease by angioscopic analysis

Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial)

HIV-negative Primary Bone Marrow Hodgkin Lymphoma Manifesting with a High Fever Associated with Hemophagocytosis as the Initial Symptom: A Case Report and Review of the Previous Literature

The principles and practice of research ethics

Cancer types applicable to efficacy assessment using real-world data analyzed from PMDA-approved data

Efficacy evaluation of anticancer agents in single-arm clinical trials: analysis of review reports from Pharmaceuticals and Medical Devices Agency

Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide

Cellular senescence induction by retinoid on adult T-cell leukemia cells

Trib1 and Trib2 inhibit granulocytic differentiation by suppressing Akt pathway

Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate

Thromboembolism in TKI therapy

Efficacy of Rituximab Monotherapy for an Elderly Hemodialysis Patient with Primary Cardiac Lymphoma

Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL‐6 production in lymphoma cells

Long-Term Clinical Outcomes of the Patients with Chronic Myeloid Leukemia Treated with Nilotinib as the 1St-Line Tyrosine Kinases Inhibitor at the Kindai university hospital

Hypersensitivity of Ph-positive lymphoid cell lines to rapamycin: Possible clinical application of mTOR inhibitor

Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma

Analysis of gemcitabine therapy for relapsed or refractory malignant lymphoma in one institute

Treatment for de novo chronic myeloid leukemia in chronic phase

Suchergebnisse filtern